| G45.02 | Arteria-vertebralis-Syndrom mit Basilaris-Symptomatik: Komplette Rückbildung innerhalb von 1 bis 24 Stunden |
|---|---|
| I10.0 | Benigne essentielle Hypertonie |
| E78.1 | Reine Hypertriglyzeridämie |
| ICD | Diagnosis |
|---|---|
| G45.02 | Arteria-vertebralis-Syndrom mit Basilaris-Symptomatik: Komplette Rückbildung innerhalb von 1 bis 24 Stunden |
| I10.0 | Benigne essentielle Hypertonie |
| E78.1 | Reine Hypertriglyzeridämie |
| PZN or GTIN | 15577596 |
|---|---|
| Vendor | ratiopharm GmbH |
| Drug | ASS -ratiopharm PROTECT 100 mg magensaftres. Tabl. |
| Ingestion amount | 0 - 1 - 0 - 0 |
| Ingestion unit | Pills |
| PZN or GTIN | 01970060 |
|---|---|
| Vendor | 1 A Pharma GmbH |
| Drug | Simvastatin-1A Pharma 20mg Filmtabletten |
| Ingestion amount | 0 - 0 - 20 - 0 |
| Ingestion unit | mg |
| PZN or GTIN | 01983625 |
|---|---|
| Vendor | Zentiva Pharma GmbH |
| Drug | RamiLich 5mg Tabletten |
| Ingestion amount | 0 - 1 - 0 - 1 |
| Ingestion unit | Pills |
| PZN or GTIN | 01035874 |
|---|---|
| Vendor | ALIUD Pharma GmbH |
| Drug | Moxonidin AL 0.2mg Filmtabletten |
| Ingestion amount | 0 - 0.2 - 0 - 0 |
| Ingestion unit | mg |
| PZN-Code | Vendor | Drug | Ingestion amount | Ingestion unit |
|---|---|---|---|---|
| 15577596 | ratiopharm GmbH | ASS -ratiopharm PROTECT 100 mg magensaftres. Tabl. | 0 - 1 - 0 - 0 | Pills |
| 01970060 | 1 A Pharma GmbH | Simvastatin-1A Pharma 20mg Filmtabletten | 0 - 0 - 20 - 0 | mg |
| 01983625 | Zentiva Pharma GmbH | RamiLich 5mg Tabletten | 0 - 1 - 0 - 1 | Pills |
| 01035874 | ALIUD Pharma GmbH | Moxonidin AL 0.2mg Filmtabletten | 0 - 0.2 - 0 - 0 | mg |
| Contact type | Person |
|---|---|
| Name | Wolfgang Retter |
| Date of birth | 14.06.1989 |
| Phone number | +491711511660 |
| testpatient@rettungsladen.de |
| Contact type | Name | Date of birth | Phone number | |
|---|---|---|---|---|
| Person | Wolfgang Retter | 14.06.1989 | +491711511660 | testpatient@rettungsladen.de |
| Power of Attorney | |
|---|---|
| Custody Order | |
| Patient Decree | |
| Organ donation authorisation | - |